Who Paid My Doc
Christina Mitchem-Walter
Pediatrics Swanton, OH Medical Doctor
NPI 1992789853 CMS profile 180772
1 Turtle Creek Cir, Ste F, Swanton, OH 43558
General payments
$4,622
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Christina Mitchem-Walter of Swanton, OH is reported in the CMS Open Payments database as having received $4,622 across 320 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $82 | 4 | |
| 2024 | General | $103 | 6 | |
| 2023 | General | $758 | 42 | |
| 2022 | General | $1,378 | 94 | |
| 2021 | General | $1,143 | 85 | |
| 2020 | General | $569 | 44 | |
| 2019 | General | $591 | 45 |
Beside peers
- Christina Mitchem-Walter
- Pediatrics median
- Middle half of Pediatrics
- National median
In program year 2025, general payments to Christina Mitchem-Walter were reported at $82. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.
Show as a table
| Year | Christina Mitchem-Walter | Pediatrics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $591 | $86 | $31–$183 | $163 |
| 2020 | $569 | $49 | $22–$110 | $114 |
| 2021 | $1,143 | $68 | $27–$158 | $132 |
| 2022 | $1,378 | $77 | $30–$173 | $149 |
| 2023 | $758 | $88 | $33–$190 | $160 |
| 2024 | $103 | $94 | $34–$206 | $164 |
| 2025 | $82 | $97 | $37–$210 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 105 drugsPart D claims
4,441
Drug cost
$246,910
Branded share of claims
21.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Rybelsus Semaglutide | Brand | 36 | $55,848 | |
| Ozempic Semaglutide | Brand | 31 | $52,465 | |
| Eliquis Apixaban | Brand | 17 | $30,842 | |
| Xarelto Rivaroxaban | Brand | 16 | $23,813 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 12 | $6,233 | |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 24 | $5,017 | |
| Azstarys Serdexmethylphen/Dexmethylphen | Brand | 11 | $4,779 | |
| Lisdexamfetamine Dimesylate | Generic | 16 | $3,276 | |
| Atorvastatin Calcium | Generic | 281 | $3,062 | |
| Levothyroxine Sodium | Generic | 247 | $2,690 |
The 10 drugs with the highest cost, of 105 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 42 billing codesPaid by Medicare
$54,288
Medicare patients
139
Services billed
1,137
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 60% | |
| Depression | 34% | |
| Diabetes | 27% | |
| Chronic kidney disease | 27% | |
| Ischemic heart disease | 25% | |
| Osteoporosis | 19% | |
| Atrial fibrillation | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Pcv20 vaccine im 90677 | Office | 14 | 14 | $4,052 |
| Vaccine for influenza for injection into muscle 90653 | Office | 29 | 29 | $2,373 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
320 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatrics in Ohio
Related records
Pediatrics in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Pediatrics
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.